中华骨科杂志
中華骨科雜誌
중화골과잡지
CHINESE JOURNAL OF ORTHOPAEDICS
2011年
10期
1049-1055
,共7页
张为%王会旺%焦甲勋%王云霞%杨大龙%丁文元%申勇
張為%王會旺%焦甲勛%王雲霞%楊大龍%丁文元%申勇
장위%왕회왕%초갑훈%왕운하%양대룡%정문원%신용
腰痛%椎间盘切除术,经皮%导管消融术
腰痛%椎間盤切除術,經皮%導管消融術
요통%추간반절제술,경피%도관소융술
Low back pain%Diskectomy,percutaneous%Catheter ablation
目的 探讨在Disc-FX通道系统辅助下采用髓核摘除、射频消融和纤维环成型的“三合一”技术治疗椎间盘源性腰痛的早期临床疗效.方法 2010年2月至2011年2月,我院对40例椎间盘源性腰痛患者行Disc-FX通道系统辅助下的“三合一”技术治疗,其中男22例,女18例;年龄32~58岁,平均38.7岁.对治疗前和术后1周、3个月、6个月及末次随访时的腰痛视觉模拟评分(visual analog scale,VAS)、下肢痛VAS评分及末次随访Macnab评分进行对比分析.结果 手术时间20~40 min,平均26 min.术后随访6~18个月,平均13.8个月.术后未发现手术相关并发症.术后1周、3个月、6个月以及末次随访时腰痛VAS评分分别为:(1.05±0.68)分、(1.15±0.70)分、(1.00±0.62)分和(0.95±0.63)分,与术前腰痛VAS评分(6.60±1.47)分比较差异均有统计学意义;术后1周、3个月、6个月及末次随访时下肢疼痛VAS评分分别为(1.10±0.74)分、(1.15±0.70)分、(1.10±0.72)分和(0.95±0.54)分,与术前(3.05±1.23)分比较差异均有统计学意义.按照Macnab评分标准,末次随访时优20例,良17例,可2例,差1例,优良率为92.5%(37/40).1例患者术后1个月时复发.结论 Disc-FX系统辅助下的“三合一”技术治疗椎间盘源性腰痛短期内能取得满意疗效,但其远期效果仍待进一步观察.
目的 探討在Disc-FX通道繫統輔助下採用髓覈摘除、射頻消融和纖維環成型的“三閤一”技術治療椎間盤源性腰痛的早期臨床療效.方法 2010年2月至2011年2月,我院對40例椎間盤源性腰痛患者行Disc-FX通道繫統輔助下的“三閤一”技術治療,其中男22例,女18例;年齡32~58歲,平均38.7歲.對治療前和術後1週、3箇月、6箇月及末次隨訪時的腰痛視覺模擬評分(visual analog scale,VAS)、下肢痛VAS評分及末次隨訪Macnab評分進行對比分析.結果 手術時間20~40 min,平均26 min.術後隨訪6~18箇月,平均13.8箇月.術後未髮現手術相關併髮癥.術後1週、3箇月、6箇月以及末次隨訪時腰痛VAS評分分彆為:(1.05±0.68)分、(1.15±0.70)分、(1.00±0.62)分和(0.95±0.63)分,與術前腰痛VAS評分(6.60±1.47)分比較差異均有統計學意義;術後1週、3箇月、6箇月及末次隨訪時下肢疼痛VAS評分分彆為(1.10±0.74)分、(1.15±0.70)分、(1.10±0.72)分和(0.95±0.54)分,與術前(3.05±1.23)分比較差異均有統計學意義.按照Macnab評分標準,末次隨訪時優20例,良17例,可2例,差1例,優良率為92.5%(37/40).1例患者術後1箇月時複髮.結論 Disc-FX繫統輔助下的“三閤一”技術治療椎間盤源性腰痛短期內能取得滿意療效,但其遠期效果仍待進一步觀察.
목적 탐토재Disc-FX통도계통보조하채용수핵적제、사빈소융화섬유배성형적“삼합일”기술치료추간반원성요통적조기림상료효.방법 2010년2월지2011년2월,아원대40례추간반원성요통환자행Disc-FX통도계통보조하적“삼합일”기술치료,기중남22례,녀18례;년령32~58세,평균38.7세.대치료전화술후1주、3개월、6개월급말차수방시적요통시각모의평분(visual analog scale,VAS)、하지통VAS평분급말차수방Macnab평분진행대비분석.결과 수술시간20~40 min,평균26 min.술후수방6~18개월,평균13.8개월.술후미발현수술상관병발증.술후1주、3개월、6개월이급말차수방시요통VAS평분분별위:(1.05±0.68)분、(1.15±0.70)분、(1.00±0.62)분화(0.95±0.63)분,여술전요통VAS평분(6.60±1.47)분비교차이균유통계학의의;술후1주、3개월、6개월급말차수방시하지동통VAS평분분별위(1.10±0.74)분、(1.15±0.70)분、(1.10±0.72)분화(0.95±0.54)분,여술전(3.05±1.23)분비교차이균유통계학의의.안조Macnab평분표준,말차수방시우20례,량17례,가2례,차1례,우량솔위92.5%(37/40).1례환자술후1개월시복발.결론 Disc-FX계통보조하적“삼합일”기술치료추간반원성요통단기내능취득만의료효,단기원기효과잉대진일보관찰.
Objective To investigate the clinical efficacy of the 3-in-1 technique of Disc-FX system,namely:discectomy,radiofrequency ablation and annuloplasty for discogenic low back pain in the early stage.Methods From February 2010 to February 2011,40 patients with the discogenic low back pain underwent discectomy,radiofrequency ablation and annuloplasty using Disc-FX system were retrospectively analyzed,including 22 males and 18 females with an average age of 38.7 years (range,32-58 years).The visual analogue scale (VAS) scoring was applied to evaluate the back and low limb pain at preoperative,postoperative 1week,3 months,6 months,and last follow-up.The Macnab score was also evaluated at last follow-up.Results All the patients were followed up for average 13.8 months (range,6-18 months).The operative time averaged 26 min (range,20-40 min).No surgical complication was found during the follow-up.The VAS of preoperative low back pain was 6.60±1.47,VAS score of low back pain at postoperative 1 week,3 months,6 months,and final follow-up were 1.05±0.68,1.15±0.70,1.00±0.62,0.95±0.63,respectively.The postoperative VAS of low back pain decreased significantly compared with that preoperative.The VAS of preoperative limb pain was 3.05±1.23,VAS score of limb pain at postoperative 1 week,3 months,6 months,and final follow-up after operation were 1.10±0.74,1.15±0.70,1.10±0.72,0.95±0.54,respectively.The postoperative VAS of limb pain decreased significantly compared with that preoperative.The evaluation of Macnab score were excellent in 20 patients,good in 17,fair in 2,and poor in 1,suggesting an effective rate of 92.5% (37/40).Conclusion Disc-FX system,which combined three surgical technique in one procedure,provides a new choice for orthopedics to treat discogenic low back pain.It can give satisfactory clinical outcomes during a short-term followup,but the long term clinical outcomes remains unknown.